Icon

VANCOMYCIN (nda213895)- (5GM/100ML (50MG/ML))

VANCOMYCIN XELLIA PHARMS APS
5GM/100ML (50MG/ML)
No No
2035-Nov-06 Expired
None None
None No
Vancomycin Injection is a glycopeptide antibacterial indicated in adult and pediatric patients less than 18 years of age as follows: • Vancomycin Injection administered intravenously is indicated for the treatment of: • Septicemia • Infective Endocarditis • Skin and Skin Structure Infections • Bone Infections • Lower Respiratory Tract Infections • Vancomycin Injection administered orally is indicated for the treatment of: • Clostridioides difficile-associated diarrhea • Enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains)
0 0 0
Total Other Developers 30
Drugs with Suitability No
5GM/100ML (50MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.